The Embryo Research Licensing Committee of the NHMRC (NHMRC Licensing Committee) is obliged by section 29 of the Research Involving Human Embryos Act 2002 to maintain a public database containing the following information in relation to each licence authorising the use of excess ART embryos:
- the name of the person to whom the licence was issued;
- a short statement about the nature of the uses of excess ART embryos that are authorised by the licence;
- any conditions to which the licence is subject;
- the number of excess ART embryos in respect of which use is authorised by the licence;
- the date on which the licence was issued; and
- the period throughout which the licence is to remain in force.
Information made public must not be such as to disclose confidential commercial information.
Licence Conditions
Licences issued by the NHMRC Licensing Committee for the use of excess Assisted Reproductive Technology (ART) embryos or human eggs or the creation and/or use of other embryos are subject to conditions. Licences are also subject to the provisions of the Research Involving Human Embryos Act 2002 and the Prohibition of Human Cloning for Reproduction Act 2002. The sections below describe Standard and Special Licence conditions.
Standard Conditions
Standard Conditions apply to all licences unless a particular Standard Condition is specifically excluded by the Special Conditions for a particular licence.
Special Conditions
Special licence conditions relate to a particular licence and include conditions about the number of excess ART embryos or eggs authorised for use, the number of other embryos authorised to be created or used, the people authorised to create and/or use them and the authorised sites, as well as any other special conditions determined by the NHMRC Licensing Committee.
See the table below for details on the Licenses, including the Special Conditions.
Current Licences issued under s.21 of the Research Involving Human Embryos Act 2002
|
Licence No |
Organisation |
Licence Title |
Date of issue |
Status |
|---|---|---|---|---|
|
Genea Limited |
Improvement in Laboratory Conditions for Embryo Culture |
16 April 2004 |
Expired | |
|
Genea Limited |
Effect of an Additive on Embryo Culture: Analysis of Growth and Epigenetic Programming |
16 April 2004 |
Expired | |
|
Genea Limited |
Development of Methods for Preimplantation Genetic and Met`abolic Evaluation of Human Embryos |
16 April 2004 |
Current to 16 April 2014 | |
|
Genea Limited |
Development of Human Embryonic Stem (ES) Cells |
16 April 2004 |
Current to 16 April 2014 | |
|
Melbourne IVF Limited |
Development of testing procedures for unbalanced chromosome errors in human embryos |
16 April 2004 |
Suspended | |
| 309710 v14 (PDF, 157KB) | Genea Limited | Derivation of human embryonic stem cells from embryos identified through preimplantation genetic diagnosis to be affected by known serious monogenic conditions | 7 May 2007 | Current to 7 May 2013 |
| 309712 v10 (PDF, 151KB) | Genea Limited |
Reproducible production of human embryonic stem cell lines from somatic cell nuclear transfer (SCNT) of nuclei from human cumulus cells into clinically unusable human eggs. | 16 September 2008 | Current to 16 September 2013 |
| 309713 v10 (PDF, 151KB) | Genea Limited |
Reproducible production of human embryonic stem cell lines from somatic cell nuclear transfer (SCNT) of nuclei from adult human fibroblasts into clinically unusable human eggs. | 16 September 2008 | Current to 16 September 2013 |
| 309714 v10 (PDF, 152KB) |
Sydney IVF Limited (trading as Genea) |
Reproducible production of human embryonic stem cell lines from somatic cell nuclear transfer (SCNT) of nuclei from previously established human embryonic stem cell lines into clinically unusable human eggs. | 16 September 2008 | Current to 16 September 2013 |
| 309716 v3 (PDF, 106KB) | Monash Institute of Medical Research and Fertility Australia, (trading as Fertility East Assisted Conception Clinic) | Production of human embryonic stem cell lines from parthenogenetic activation of matured human eggs obtained from clinically unusable immature eggs | 29 June 2011 | Current to 29 June 2013 |
| 309718 v2 (PDF, 100KB) | Genea Limited | Use of excess ART embryos and clinically unusable eggs for validation of an IVF device | 8 December 2011 | Current to 8 December 2014 |
| 309719 v1 (PDF, 98KB) | Genea Limited | Use of excess ART embryos for the development of improved IVF culture media | 28 March 2012 | Current to 28 March 2015 |